Last reviewed · How we verify
NCT07279220
Safety and Effectiveness of the Vascular Closure Device for Femoral Artery Hemostasis in Patients of Femoral Artery Puncture
NA trial testing Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd. in Femoral Artery Puncture in 238 participants. Not yet recruiting.
2 March 2026
Quick facts
| Lead sponsor | Shanghai Bomaian Medical Technology Co., Ltd |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 238 |
| Start date | 29 December 2025 |
| Primary completion | 2 March 2026 |
| Estimated completion | 15 May 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- Vascular Closure Device Manufactured by Shanghai Bomaian Medical Technology Co., Ltd.
- MynxGrip Vascular Closure Device Manufactured by Cordis US Corp
Conditions studied
- Femoral Artery Puncture — all drugs for Femoral Artery Puncture →
- Vascular Closure Device — all drugs for Vascular Closure Device →
- Hemostasis — all drugs for Hemostasis →
Sponsor
Shanghai Bomaian Medical Technology Co., Ltd
Who can join
Adults 18 to 80, any sex, with Femoral Artery Puncture or Vascular Closure Device. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to verify the safety and effectiveness of the Vascular Closure Device manufactured by Shanghai Bomaian Medical Technology Co., Ltd. for femoral artery hemostasis in patients of femoral artery puncture.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07279220
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Shanghai Bomaian Medical Technology Co., Ltd trials
Trials by the same sponsor.
- NCT06029569 — Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula · NA · unknown
- NCT05662618 — To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07279220 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Bomaian Medical Technology Co., Ltd
- Last refreshed: 12 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07279220.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing